The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still's disease
Abstract Currently, the criteria used to classify patients with SJIA are different from those used for AOSD. However, it has been recognized that the existing terms are too narrow, subdividing the Still's population unnecessarily between pediatric-onset and adult-onset disease and excluding an...
Saved in:
Main Authors: | Peter A. Nigrovic (Author), Fabrizio de Benedetti (Author), Yukiko Kimura (Author), Daniel J. Lovell (Author), Sebastiaan J. Vastert (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA
by: Grant Schulert, et al.
Published: (2024) -
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study
by: Fabrizio de Benedetti, et al.
Published: (2024) -
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13-14, 2022
by: Rashmi Sinha, et al.
Published: (2024) -
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?
by: Scott W. Canna, et al.
Published: (2024) -
NextGen Public Health Surveillance and the Internet of Things (IoT)
by: Kirti Sundar Sahu, et al.
Published: (2021)